Theres more to it so lets get into the magical mRNA math, which is not looking very good….
FDA approved mFLUSIVA on August 5, 2026, licensing Moderna’s mRNA-1010 as the first mRNA influenza vaccine in the United States. Adults 50 to 64 got full approval. Adults 65 and older, the group most likely to die of influenza, got accelerated approval with the confirmatory study deferred until after the product is already in arms.
On August 19, epidemiologist Nicolas Hulscher and physicians Peter McCullough and John Catanzaro published a reanalysis of the FDA clinical data and sent it to Secretary Kennedy, demanding immediate withdrawal of the license. It is a preprint and has not been peer reviewed. Every figure in it comes from FDA’s and Moderna’s own filings.
What the shot prevents. The pivotal trial, P304, published in the New England Journal of Medicine, randomized 40,703 adults over 50 one-to-one. The comparator was an ordinary licensed flu vaccine, not a placebo. Relative efficacy was 26.6 percent. Absolute risk reduction was under one percent.
Influenza hospitalizations came to 4 in the mRNA group against 8 in the comparator group. Four avoided across roughly 20,000 vaccinations works out to one hospitalization prevented per 5,017 people injected. The entire benefit case rests on twelve hospitalizations.
What the record shows on deaths. FDA’s clinical review, dated the day of approval, pooled about 72,000 participants across four trials, roughly 36,000 per arm. Reviewers recorded an imbalance in deaths coded to the term “death (without further specification),” meaning no cause was ever written down.
23 events in the mRNA-1010 group versus 9 in the comparator group. Pooled with related categories, 29 versus 12.
Fourteen excess deaths of unrecorded cause across 36,000 vaccinations is one per 2,571. Set against the same denominator as the benefit, that is approximately two excess unexplained deaths for every hospitalization prevented. All-cause mortality across the pooled database was 102 against 97.
FDA called a causal relationship “unlikely,” citing no clustering inside the 28 days after injection, where the counts were 3 versus 2. The other 20 unexplained deaths in the mRNA group occurred after day 28.
The same document states that “definitive causal assessment is precluded by the absence of autopsies in all 29 affected mRNA-1010 recipients and lack of systematic cause-of-death adjudication.” Not one autopsy was performed. Reviewers concluded that overall rates of serious adverse events were “balanced between study groups.”
The math, step by step
Step 1 — the benefit. From the NEJM trial, 20,350 people got mRNA-1010 and 20,353 got an ordinary flu shot.
Flu hospitalizations were 4 versus 8. So 4 were avoided.
20,350 ÷ 4 = one hospitalization prevented per 5,088 people vaccinated. The reanalysis authors published 5,017 because they used a slightly tighter efficacy population. Either way, about one per 5,000.
Step 2 — the deaths. From FDA’s own clinical review, pooled across four trials, about 36,000 people per arm.
Deaths coded “death (without further specification),” meaning no cause was ever recorded, were 23 versus 9. That is 14 excess.
36,000 ÷ 14 = one excess unexplained death per 2,571 people vaccinated.
Step 3 — put them on the same scale.
5,017 ÷ 2,571 = 1.95
So for every one flu hospitalization the shot prevents, there are roughly two excess deaths in the mRNA group that nobody wrote a cause for.
That is the ratio. It is arithmetic on FDA’s and NEJM’s own published counts. Anyone reading this can check it with a calculator, and you may want to check it yourself!
The rebuttal. A site called Stop Anti-Vax Propaganda published a response calling the paper propaganda and a gross misrepresentation. It is a bunch of shills. They never identify a single arithmetic error. Their only real objection is that the authors treat unexplained deaths as vaccine-caused.
The rest of the record. Grade 3 reactions, severe enough to stop normal daily activity, hit 6.4 percent of mRNA recipients against 1.0 percent of comparator recipients. The reanalysis notes that no influenza-mortality endpoint was specified or collected anywhere in the development program, for a product licensed largely on preventing severe outcomes.
How it got approved. Then-CBER director Vinay Prasad rejected the application in February 2026, finding the trial not adequate and well-controlled. FDA reversed roughly two weeks later after a meeting with the sponsor. Prasad was gone by the end of April. The advisory panel voted 9 to 0 in favor. Epidemiologist Michael Osterholm said of the reversal, “We don’t have any idea why they reversed course.”
Moderna and FDA have not publicly responded to the reanalysis.
This demonic arithmetic is why IoJ is in federal court.
If mRNA products meet FDA’s own written definition of gene therapy, then calling them vaccines was a classification decision carrying legal consequences the agency has dodged for five years. Our mandamus forces that answer onto the record. It attacks the mRNA platform as unlawfully classified and unlawfully on the market, and as far as anyone here knows it is the only case in front of a judge that can reach the question. It is filed in my name only because IoJ could not afford an attorney to file it in the organization’s.
My mother and father each took three Moderna doses and died eleven days apart. No causation finding was ever made but I believe the mRNA poison killed them both.
I am asking a court to make FDA answer to the unreasonable risk of mRNA in masses.
The attorney legal fund sits at just over $800. That is a real start from people who have stepped up as hero’s to help, and it is close to the first tier, but it is not enough yet to do what humanity needs us all to do to stop this demonic math with legal help on board.
They reversed a rejection of this shot in two weeks. They have not answered us in years. Without prompt legal remedy this mRNA poison goes into arms this flu season.
Thank you, and God bless. This is close to my heart and many of you and your loved ones were affected. Together we can still take proper legal action and shut it down!
It’s demonic math - yes - but we are stronger and light will win over dark!
— Lady Xylie, IOJ
Baby steps we will stand up for whats right to take real legal action together because someone has to stop the mRNA deaths
Fund the attorney for mRNA mandamus
This story reached us through Exposing the Darkness. IoJ dug in and assembled all we could find to really expose this evil situation & bring it to light! Do not join them. EXPOSE them!
Comments
Nothing yet. Say the first thing.
Sign in to join the conversation.